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levels in HUVEC and HMVEC
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Abstract
Background: Endothelial dysfunction precedes pathogenesis of vascular complications in diabetes. In recent years,
the mechanisms of endothelial dysfunction were investigated to outline strategies for its treatment. However, the
therapies for dysfunctional endothelium resulted in multiple clinical trial failures and remain elusive. There is a need
for defining hyperglycemia-induced endothelial dysfunction with both generic and specific dysfunctional changes
in endothelial cells (EC) using a systems approach. In this study, we investigated hyperglycemia-induced endothelial
dysfunction in HUVEC and HMVEC. We investigated hyperglycemia-induced functional changes (superoxide (O2‾),
and hydrogen peroxide (H2O2) production and mitochondrial membrane polarization) and gene expression
fingerprints of related enzymes (nitric oxide synthase, NAD(P)H oxidase, and reactive oxygen species (ROS)
neutralizing enzymes) in both ECs.
Method: Gene expression of NOS2, NOS3, NOX4, CYBA, UCP1, CAT, TXNRD1, TXNRD2, GPX1, NOX1, SOD1, SOD2,
PRDX1, 18s, and RPLP0 were measured using real-time PCR. O2‾ production was measured with dihydroethidium
(DHE) fluorescence measurement. H2O2 production was measured using Amplex Red assay. Mitochondrial
membrane polarization was measured using JC-10 based fluorescence measurement.
Results: We showed that the O2‾ levels increased similarly in both ECs with hyperglycemia. However, these
endothelial cells showed significantly different underlying gene expression profile, H2O2 production and
mitochondrial membrane polarization. In HUVEC, hyperglycemia increased H2O2 production, and hyperpolarized
mitochondrial membrane. ROS neutralizing enzymes SOD2 and CAT gene expression were downregulated. In
contrast, there was an upregulation of nitric oxide synthase and NAD(P)H oxidase and a depolarization of
mitochondrial membrane in HMVEC. In addition, ROS neutralizing enzymes SOD1, GPX1, TXNRD1 and TXNRD2 gene
expression were significantly upregulated in high glucose treated HMVEC.
Conclusion: Our findings highlighted a unique framework for hyperglycemia-induced endothelial dysfunction. We
showed that multiple pathways are differentially affected in these endothelial cells in hyperglycemia. High
occurrences of gene expression changes in HMVEC in this study supports the hypothesis that microvasculature
precedes macrovasculature in epigenetic regulation forming vascular metabolic memory. Identifying genomic
phenotype and corresponding functional changes in hyperglycemic endothelial dysfunction will provide a suitable
systems biology approach for understanding underlying mechanisms and possible effective therapeutic
intervention.
Keywords: Endothelial dysfunction, Microvascular dysfunction, Systems biology, Oxidative stress, Hyperglycemia,
HUVEC, HMVEC, Vascular metabolic memory
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Background
Diabetes, a complex metabolic syndrome, is a rapidly
growing public health burden in both developed and developing countries. Among all pathophysiologies associated
with diabetes, micro and macrovascular complications are
implicated in most conditions leading to morbidity and
mortality in diabetic patients [1]. Hyperglycemic condition
associated with diabetes dysregulates endothelial function
that leads to initiation and propagation of vascular complications and dysfunction [2,3]. The understanding and
amelioration of endothelial dysfunction is important for
diabetic vascular complications.
The onset of endothelial dysfunction begins with
disruption of balance amongst vasorelaxation and vasoconstriction factors. Under hyperglycemic condition, an
increase in intracellular reactive oxygen species (ROS) is responsible for pathophysiological changes including nitric
oxide (NO) synthesis inhibition, vascular inflammation, insulin resistance, neovascularization, leukocyte adhesion,
and protein and macromolecule glycation [4-6]. Pharmacological therapies including antioxidants, vitamin E, Larginine, calcium antagonists, β-blockers, renin-angiotensin
system inhibitors, statins, insulin-resistance improving
drugs, erythropoietin, and tetrahydrobiopterin have been
shown to ameliorate endothelial dysfunction [2,5,7-9].
However, their efficacy on treating dysfunctional endothelium varies with different disorders and in different parts
of vasculature [2,5,7-9]. Several of the clinical trials with
antioxidants have failed to show benefits even though
in vitro and animal studies have shown significant improvement [6,9]. Our understanding of the mechanisms
of hyperglycemia-induced oxidative stress and resulting
endothelial cell dysfunction from a systems perspective is
lacking. While the reason for justifying differential efficacies of therapeutic strategies remains unclear, these findings have raised the need for improving the understanding
for hyperglycemia-induced pathogenesis of endothelial
dysfunction in different parts of vasculature.
In normal physiology, endothelial cells (EC) regulate
vascular homeostasis through NO production and its bioavailability [10]. Even though critical for wide ranges of
cell signaling and cell-cell communication processes, NO
is susceptible to inactivation through intracellular superoxide (O2‾) [10]. In hyperglycemia, intracellular O2‾ increases from sources including NAD(P)H oxidase family
enzymes, xanthine oxidase, cyclooxygenase, uncoupled
constitutive nitric oxide synthase (eNOS), mitochondrial
electron transport, glucose oxidase, and lipooxygenase
[6,11-14]. Intracellular O2‾ is a relatively short-lived species, which can get dismutated by superoxide dismutase
(SOD) enzyme and self-dismutation to hydrogen peroxide
(H2O2) in addition to its rapid reaction with NO.
Unlike O2‾, H2O2 is more stable ROS [15]. High glucose exposure increases H2O2, which is a result of rapid
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dismutation of O2‾ in mitochondria and an increase in
NAD(P)H oxidase-4 (NOX4) activity in cytosol [16,17].
The lower level of H2O2 causes vasorelaxation along
with induction and activation of nitric oxide synthase
(NOS) [15,18], whereas the higher level of H2O2 promote vasoconstriction and causes oxidative damage to
the vasculature [18]. During oxidative stress condition,
the intracellular H2O2 levels are tightly regulated through
i) a direct involvement of catalase, peroxiredoxin and
thioredoxin enzyme networks, and ii) an indirect involvement from uncoupling proteins, and Nrf-2 expression
[19,20]. Therefore, endothelial function is regulated though
a complex network of regulation in NO production, O2‾
production and dismutation, and peroxide clearance.
For a generic understanding of hyperglycemia-mediated
oxidative stress and endothelial dysfunction, the current
trend in literature emphasizes the studying and understanding of individual sources of endothelial dysfunction
in a specific type of endothelial cells or vasculature segment. In normal physiology, endothelial cells originated
from different organs and parts of vasculature express different functional characteristics that are based on endothelial function, gene expression, and proteomic profile at
homeostasis [21-23]. Such functional differences in endothelial cells can be precursors of their variable behavior
under both physiological and pathophysiological conditions [24].
Hyperglycemia has been shown to increase O2‾ production and induce endothelial dysfunction. However,
the production and involvement of O2‾ sources varies
across ECs from different parts of vasculature [25-28].
In human glomerular endothelial cells (HGEC) and human aortic endothelial cells (HAEC), the major source
of hyperglycemia-induced oxidative stress and O2‾
production is uncoupled eNOS and NAD(P)H oxidase,
respectively [26,28]. Hyperglycemia-induced endothelial
dysfunction is also differentially regulated in ECs from
different part of the vasculature. Karabach et al. [29]
showed that HUVEC and EA.hy.926 have significantly
different cell viability and O2‾ formation in hyperglycemia. Pala et al. [30] showed that HAEC and HMVEC
have differential dipeptidyl peptidase-4 expression and
activity levels in hyperglycemia. Wang et al. [24] showed
that endothelial cells derived from myocardial microvasculature and aorta of type 2 diabetic rats differentially
expressed growth factors and impaired angiogenesis only
in myocardial microvascular endothelial cells.
These studies show a need for the understanding of
mechanisms for the differences in hyperglycemia-induced
endothelial cell functional changes across the vasculature.
Further studying ECs from different parts of the vasculature will enhance the system wide understanding for
hyperglycemia-induced vascular dysfunction [31]. In this
study, we investigated hyperglycemia-induced endothelial
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dysfunction in HUVEC and HMVEC. To compare changes
in functional behavior of both cell types, levels of O2‾,
H2O2, and mitochondrial membrane polarization were
measured following 24 hours of 25 mM D-glucose exposure. In addition, we measured gene expression changes important to these functional changes including nitric oxide
synthase enzymes (NOS2 and NOS3), NAD(P)H oxidase
enzymes (NOX1, NOX4, and CYBA), ROS neutralizing enzymes such as superoxide dismutase (SOD1 and SOD2),
catalase (CAT), peroxiredoxin (PRDX1), glutathione peroxidase 1 (GPX1) and thioredoxin reductase 1 and 2
(TXNRD1 and TXNRD2), oxidative stress activated transcription factor, Nrf-2, (NFE2L2), and uncoupling protein
1(UCP1). Findings from this study outline a relationship
between functional changes and the underlying genomic
phenotype to improve understanding of differential effects
of hyperglycemia on endothelial cells.

Methods
Cell culture and experimental protocol

Primary HUVEC and HMVEC were purchased from
Lonza, MD. HUVEC and HMVEC were grown using
EGM-2 media supplemented with Bullet kit (Lonza,
MD). Media was changed every 48 hours until cells
reached 80 to 90% confluency. At confluency, cells were
either subcultured or used for experiments. For all experiments, cells growing at passage either 4 or 5 were
used and experiments were carried out using M199
media supplemented with low serum growth supplement
kit (Life Tech, CA). This media was also used as control
and had 5.6 mM D-glucose. For high glucose treatment,
D-glucose was added to M199 for a final concentration
of 25 mM (HG-M199). For experiments, HUVEC and
HMVEC were seeded into separate 6 well plates. After
24 hours of seeding, half of the sample wells in 6 well
plates were treated with HG-M199 media, and the other
half were treated with the control media.

O2‾ measurement using DHE fluorescence

Dihydroethidium (DHE), was used to measure O2‾ in
HUVEC and HMVEC following 24 hours of treatment
with high glucose. At the end of the treatment period, cells
were washed and incubated with 5 μM DHE in phenol
red-free treatment medium for 1 hour. During the incubation period cells, we measured 2-hydroxyethidium (2-OHE+), a specific product from DHE and O2‾ interaction,
intensity using a microplate reader. Excitation (Ex) of 508 ±
10 nm and emission (Em) of 560 ± 20 nm were used for a
specific measurement of 2-OH-E+ [32-34]. Alternatively,
fluorescence microscopy was also used to capture differences in fluorescence intensities at the end of 1 hour incubation with DHE.
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H2O2 measurement

After treating cells, media supernatants were collected to
measure H2O2 using Amplex® Red based assay (Life Tech,
CA). In brief, at the time interval of 3, 6, 9, and 24 hours
media supernatants were collected and stored in aliquots
at −80°C and different wells were used for each time point.
Supernatants were quickly thawed and centrifuged immediately before use. As per manufacturer’s instruction, a
lower H2O2 concentration range was used for a standard
curve to quantify H2O2 in supernatants.
Mitochondrial membrane polarization measurement

JC-10 (Enzo Life Sciences, NY) was used to measure mitochondrial membrane polarization in cells. JC-10 is a cationic fluorophore, which is rapidly taken up by cells and
mitochondria due to their negative charge. Inside mitochondria, JC-10 forms J-aggregates which emit fluorescence at 590 nm (red fluorescence). Remaining JC-10 in
cytosol maintains monomeric form and emits fluorescence
at 525 nm (green fluorescence). Uptake levels of JC-10 in
mitochondria depend on polarization state of mitochondrial membrane. Hyperpolarized mitochondria have higher
uptake of JC-10 compared to depolarized. Following the
treatment, cells were washed twice with PBS and then incubated with 1 μM JC-10 solution prepared in PR-free
M199 media for 15 minutes. After 15 minutes of incubation, cells were incubated with 1 μg/ml Hoescht 33342
(Life technologies, CA) for 10 minutes and then quickly
washed with PBS prior to fluorescence imaging and microplate reader based measurements. Microplate reader
based measurement for J-monomers and J-aggregates were
carried out at 485 ± 10 nm (Ex)/ 516 ± 10 nm (Em) and
528 ± 10 nm (Ex)/ 590 nm ± 10 (Em), respectively.
RNA extraction and reverse transcription

We used RNeasy mini kit (Qiagen, CA) to extract RNA.
During RNA extraction genomic DNA was also removed
by DNase I digest treatment. Quantity and purity of extracted RNA samples were analyzed using spectrophotometry prior to storing them in aliquots at −80°C. All RNA
samples were also analyzed for integrity and genomic
DNA contamination using flash gel (Lonza, MD) prior to
their use in reverse transcription. Reverse transcription reactions were performed using a high capacity cDNA reverse transcription kit (Life Technologies, CA). As per
manufacturer’s protocol, 1.5 μg of extracted RNA from
each treatment and control samples were converted to
cDNA in a 20 μl reverse transcription reaction. Following
reverse transcription, all cDNA samples were stored in aliquots at −20°C until analyzed.
Gene expression analysis

Real-time PCR was used to check gene expression levels
of NOS2, NOS3, NOX4, CYBA, UCP1, CAT, TXNRD1,
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TXNRD2, GPX1, NOX1, SOD1, SOD2, PRDX1, 18s, and
RPLP0. Synthesized cDNA from treatment and control
groups specific to both HUVEC and HMVEC were used
to setup real time-PCR reactions. Gene expression levels
of NOS2, NOS3, NOX4, CYBA, 18s and RPLP0 were
measured using Taqman gene expression assays (Life
Technologies, CA). The rest of the gene expression targets were measured using custom designed primers and
SYBR green chemistry. NCBI’s Primer-BLAST feature
was used to design primer sequences specific to UCP1:
5′-GCTCCAGGTCCAAGGTGAAT-3′ and 5′-ACAG
CGGTGATTGTTCCCAG-3′; CAT: 5′-AGGGGCCTTT
GGCTACTTTG-3′ and 5′-ACCCGATTCTCCAGCAA
CAG-3′; TXNRD1: 5′-GGAACTAGATGGGGTCTCGG3′ and 5′-TCTTGCAGGGCTTGTCCTAA-3′; TXNRD2:
5′-GGTGGACTACGTGGAACCTT-3′ and 5′-TCTGCC
ATCTTCCTCCAGTCA-3′; GPX1: 5′-CCGGGACTACA
CCCAGATGA-3′ and 5′-CGTTCTCCTGATGCCCA
AAC-3′; PRDX1: 5′-TCCTTTGGTATCAGACCCGA-3′
and 5′-TAAAAAGGCCCCTGAACGAG-3′; NOX1: 5′ATCCCCCTGAGTCTTGGAAGT-3′ and 5′-CACTTCC
ATGCTGAAGCCAC-3′; SOD1: 5′-AGCATTAAAGGAC
TGACTGAAGG-3′ and 5′-GTCTCCAACATGCCTCTC
TTC-3′; and SOD2: 5′-GTTGGGGTTGGCTTGGT
TTC-3′ and 5′- ATAAGGCCTGTTGTTCCTTGC-3′.

Fold Change

a
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All Taqman gene expression assays were setup using
Taqman gene expression mastermix (Life Technologies,
CA), and 75 ng of cDNA, from respective samples in 20 μl
PCR reactions. Using StepOne Plus System (Life Technologies, CA) real-time PCR run was setup as follows: 2
minutes at 50°C and then 10 minutes at 95°C followed by
36 cycles of 15 seconds at 95°C, 1 minute at 60°C. Rest of
the gene expression targets were measured in real-time
PCR using SYBR green based detection. All SYBR green
based PCR reactions were setup using 200 nM of forward
and reverse primers, 56.25 ng of cDNA, and Fast SYBR
green expression master mix (Life Technologies, CA) in
20 μl volume. Real-time PCR reaction compiling 20 seconds at 95°C followed by 36 cycles of 3 seconds at 95°C,
20 seconds at annealing temperature of respective primer
set, and 20 seconds at 60°C steps was used to carry out
the reaction. Following each SYBR green based PCR, melt
curve analysis and agarose gel based quality check were
performed to evaluate the quality and specificity of PCR
amplifications. Furthermore, no reverse transcription, and
no template controls were also ran for evaluating specificity of PCR amplification.
The cycle threshold (CT) values form all real-time PCR
experiments were analyzed using ΔΔCT method. Housekeeping genes 18s and RPLP0 were used for normalizing
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Figure 1 Expression levels of NOS enzymes in HUVEC, and HMVEC after 24 hours of high glucose exposure. Gene expression of NOS2
and NOS3 were measured following 24 hours of HG-M199 exposure to (a) HUVEC and (b) HMVEC. Fold changes were calculated by 2-ΔΔCT
method using 18s and RPLP0 as housekeeping genes and cells grown in M199 media with 5.6 mM D-glucose as control. **p ≤ 0.05 significantly
higher than control for respective cells type.
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gene expression from both HUVEC and HMVEC. All
gene expression results were presented as normalized fold
changes, calculated using 2-ΔΔCT, compared to control (5.6
mM D-glucose).
Data analysis

All experiments were carried out three times, except for
hydrogen peroxide measurements, which had four replicates. Data analyses on all results were carried out using
one-way analysis of variance (ANOVA) followed by Fisher’s LSD based post-hoc analysis. Comparisons were
deemed significant for p-value ≤ 0.05. All quantified results were presented as mean ± S.E.M. (standard error of
mean) in graphical representation.

Results
Gene expression of NOS and NOX family enzymes in
hyperglycemia was upregulated in HMVEC but not in HUVEC

We exposed HUVEC and HMVEC to high glucose for 24
hrs. After 24 hours of exposure, RNA was isolated and synthesized to cDNA for real-time PCR based gene expression
measurement. We measured the gene expression levels of
NOS and NOX family enzyme, which are sources of NO
and superoxide, respectively. As seen in Figure 1a, the gene

Fold Change

a

expression levels of NOS2 and NOS3 were downregulated
(though not statistically significant) in HUVEC after high
glucose exposure. High glucose exposure to HMVEC increased NOS3 (p ≤ 0.05) and NOS2 (not significant, p =
0.15) expression (Figure 1b). Following high glucose exposure, the expression of NOX family genes did not change
in HUVECs (Figure 2a) whereas the expression of
NOX1 (p ≤ 0.05), NOX4 (p ≤ 0.05), and CYBA (p = 0.07)
(Figure 2b) increased in HMVEC. Thus, high glucose induced significantly different response in NOS and NOX
family enzyme in HMVEC and HUVEC.
Hyperglycemia upregulated the gene expression of ROS
and peroxide clearance enzymes in HMVEC whereas it
downregulated in HUVEC

After 24 hours of exposure to high glucose, gene expression levels of SOD1, SOD2, CAT, GPX1, TXNRD1,
TXNRD2, and PRDX1 were measured to evaluate transcriptional changes leading to ROS and peroxide clearance in HUVEC and HMVEC. We observed an opposite
transcription regulation of ROS and peroxide clearance
enzymes in high glucose treated HUVEC and HMVEC.
As seen in Figure 3a, the expression of SOD2 and CAT
was significantly (p ≤ 0.05) downregulated in HUVEC
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Figure 2 Expression levels of NAD(P)H oxidase family enzymes in a) HUVEC, and) HMVEC cells after 24 hours of high glucose
exposure. Gene expression of NOX1, NOX4, and CYBA were measured using real-time PCR in both (a) HUVEC and (b) HMVEC. Fold changes
were calculated by 2-ΔΔCT method using 18s and RPLP0 as housekeeping genes and cells grown in M199 media with 5.6 mM D-glucose as
control. **p ≤ 0.05 significantly higher than control for HMVEC. *p ≤ 0.07 higher than control for HMVEC.
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Figure 3 Expression levels of ROS clearance enzymes in HUVEC, and HMVEC cells after 24 hours of high glucose exposure. Gene
expression of SOD1, SOD2, and CAT were measured in (a) HUVEC and (b) HMVEC following 24 hours of treatment with HG-M199. Fold changes
were calculated by 2-ΔΔCT method using 18s and RPLP0 as housekeeping genes and cells grown in M199 media with 5.6 mM D-glucose as
control. **p ≤ 0.05 significantly different than control for respective cells type.

post 24 hours of high glucose exposure. The expression
of SOD1 (p = 0.16), GPX1 (p = 0.34), TXNRD1 (p = 0.11),
TXNRD2 (p = 0.39) and PRDX1 (p = 0.11) was also downregulated (but not statistically significant) compared to
control in HUVEC (Figure 4a). High glucose exposure
upregulated gene expression of ROS and peroxide clearance enzymes in HMVEC. The expression of SOD1 (p ≤
0.05), GPX1 (p ≤ 0.0005), TXNRD1 (p ≤ 0.05) and TXNRD2
(p ≤ 0.05) was significantly upregulated in high glucose
treated HMVEC (Figures 3b and 4b). Moreover, the expression levels of SOD2 (p = 0.15), CAT (p = 0.21) and PRDX1
(p = 0.13) were also upregulated but not statistically different than the control (Figure 3b) in HMVEC. Thus, there
was an overall upregulation in expression of ROS and peroxide clearance enzymes in HMVEC whereas in HUVEC
their expression either downregulated or remained unchanged under hyperglycemia.

Hyperglycemia upregulated oxidative stress activated
transcription factor (NFE2L2) and UCP1 gene expressions
in HMVEC but not in HUVEC

We measured gene expression of NFE2L2 and UCP1 in
high glucose treated HUVEC and HMVEC following 24
hour exposure. NFE2L2 translates to Nrf-2, which is a
transcription factor for antioxidant enzymes, to maintain

cellular redox state under oxidative stress condition. As
seen in Figure 5, hyperglycemia induced a downregulation
of NFE2L2 (p = 0.19) in HUVEC whereas it upregulated
NFE2L2 expression in HMVEC (p = 0.06). Similarly, UCP1,
which uncouples the electron transport chain from oxidative phosphorylation and thereby decreases mitochondrial
ROS generation, expression was also differentially regulated in both endothelial cells. High glucose exposure induced no change in UCP1 in HUVEC (Figure 5a) whereas
the expression of UCP1 was upregulated in HMVEC (p =
0.06, Figure 5b).
Hyperglycemia increased intracellular O2‾ production, in
both endothelial cells, that was accompanied with
elevated H2O2 levels in HUVEC and not in HMVEC

In order to understand how changes in these gene expression results in overall cellular ROS generation, we
measured O2‾ and H2O2, levels in HUVEC and HMVEC.
High glucose exposure induced a similar increase in O2‾
production in both HUVEC and HMVEC but H2O2
levels were regulated differently in both endothelial cells.
Figure 6 shows the DHE measurement using fluorescence microscopy and a microplate reader. There was an
increase in O2‾ production for both endothelial cells
treated with high glucose for 24 hours as shown in DHE
fluorescence images (Figure 6a-d). Furthermore, the
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Figure 4 Expression levels of peroxide clearance enzymes in HUVEC, and HMVEC cells after 24 hours of high glucose exposure. Gene
expression of GPX1, TXNRD1, TXNRD2, and PRDX1 were measured in (a) HUVEC and (b) HMVEC following 24 hours of exposure to HG-M199.
Fold changes were calculated by 2-ΔΔCT method using 18s and RPLP0 as housekeeping genes and cells grown in M199 media with 5.6 mM
D-glucose as control. **p ≤ 0.05 significantly higher than control for HMVEC.

specific product of DHE and O2‾ interaction, 2-OH-E+,
significantly increased in both HUVEC and HMVEC
(p ≤ 0.01) after high glucose exposure (Figure 6e).
Figure 7 shows the H2O2 levels over 24 hours. Although there was no significant change in H2O2 levels at
initial time points in HUVEC, H2O2 level at 24 hours
was significantly higher than control (p ≤ 0.006) as seen
in Figure 7a. On contrary, high glucose treatment did
not change H2O2 level in HMVEC over 24 hours of exposure (Figure 7b). H2O2 production profiles were similar in controls for both cell types over 24 hours. Basal
level of H2O2 in control was higher in HUVEC than in
HMVEC. In addition, H2O2 production profiles were different and H2O2 levels were higher in hyperglycemic
HUVEC compared to HMVEC.
Hyperglycemia hyperpolarized mitochondrial membrane
in HUVEC whereas it depolarized mitochondrial
membrane in HMVEC

To understand the effect of hyperglycemia-induced change
in gene expressions and ROS level on mitochondrial activity, we measured mitochondrial membrane polarization in
HUVEC and HMVEC over 24 hours using JC-10. As seen
in Figure 8a, high glucose treated HUVEC had high red
fluorescence because of JC-10 aggregation in mitochondria.

In addition, the ratio of red to green fluorescence was significantly higher in high glucose treated HUVEC compared
to control (p ≤ 0.05, Figure 8b). This indicated that mitochondrial membrane hyperpolarized after exposure to
hyperglycemia in HUVEC. In HMVEC, high glucose exposure caused lower red fluorescence intensity (Figure 8c)
and significantly lower red to green fluorescence ratio (p ≤
0.05, Figure 8d) as compared to control. These changes in
JC-10 fluorescence indicated that HMVEC mitochondrial
membrane depolarized after exposure to hyperglycemia.
Thus, high glucose exposure induced a complete opposite
trend in mitochondrial membrane polarization in both
HUVEC and HMVEC.

Discussion
An understanding of hyperglycemia-induced endothelial
dysfunction is important for therapeutic intervention of
vascular complications in diabetes. In this study, we compared the hyperglycemia-related changes in primary human endothelial cells from both umbilical vein (HUVEC)
and microvascular (HMVEC) origins. We investigated the
regulation of hyperglycemia-induced functional changes
and gene expression fingerprints for related enzymes in
both ECs. We did not evaluate specific protein expression
and activity levels as we observed various sources and
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Figure 5 Expression levels of oxidative stress responding transcription factor and uncoupling protein in HUVEC, and HMVEC cells after
24 hours of high glucose exposure. Gene expression of NFE2L2 and UCP1 were measured in (a) HUVEC and (b) HMVEC following 24 hours of
exposure to HG-M199. Fold changes were calculated by 2-ΔΔCT method using 18s and RPLP0 as housekeeping genes and cells grown in M199
media with 5.6 mM D-glucose as control. *p ≤ 0.06 higher than control for HMVEC.

enzyme networks were affected in this study; resulting in
an overall contribution to O2‾ and H2O2 production.
Moreover, limited correlation among protein translation,
activity, and gene expression would not exclusively validate gene expression changes or vice versa [35-37].
Results from our study indicated that hyperglycemia induced consistent increase in O2‾ production in both ECs.
However, there was a differential change in underlying
gene expression profile, H2O2 and mitochondrial membrane polarization levels during high glucose exposure in
both ECs. A significant up-regulation in gene expression levels of NOS and NOX family enzymes, SOD1,
CAT, GPX1, TXNRD1, TXNRD2, NFE2L2 and UCP1
were observed in HMVEC under high glucose exposure.
On the contrary, HUVEC showed a down-regulation in
SOD2 and CAT enzymes along with elevated H2O2
levels and hyperpolarized mitochondria.
Hyperglycemia-induced differential NOS enzyme
regulation in HUVEC and HMVEC

Hyperglycemia results in endothelial dysfunction that may
be a consequence of or cause of change in NOS expression
and activity levels. Variable changes in NOS expression
have been reported in the literature for hyperglycemicendothelial cells in cell cultures, animal models and
humans [38]. We showed a non-significant downregulation

and upregulation of NOSs expression in HUVEC and
HMVEC, respectively. The expression levels of NOS3 have
been have been reported to be up, down and no change in
HUVEC [32,39]. Following 24 hours of high glucose exposure to HUVEC, we showed a non-significant downregulation in NOS3, which was similar to unchanged NOS3
levels reported by Zielonka et al. [32]. In HMVEC, we
showed that the hyperglycemia induced an upregulation of
NOS3 and NOS2 gene expression levels similar to previous
study [40]. This differential NOS expression in HUVEC
and HMVEC suggests a vasculature specific vasoregulatorygene expression regulation in hyperglycemia.
Differential NAD(P)H oxidase family enzyme regulated a
consistent O2‾ production in high glucose treated HUVEC
and HMVEC

Elevated O2‾ levels serves as a hallmark to hyperglycemia mediated oxidative stress and vascular dysfunction
[6,29,32]. We showed that DHE based measurement revealed increased O2‾ levels in both endothelial cells.
NAD(P)H oxidase family enzymes play a pivotal role in
O2‾ production in variety of endothelial cells during
hyperglycemia [41]. Their ability to regulate O2‾ production has been linked with their translocation to plasma
membrane to co-localize with other enzyme units and increased activation under hyperglycemic condition [42-44].
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Figure 6 O2‾ production in HUVEC and HMVEC cells following high glucose exposure for 24 hours. Using DHE levels of O2‾ were
measured in both HUVEC and HMVEC following 24 hours of high glucose treatment. Fluorescence imaging was used to capture DHE
fluorescence in (a-b) HUVEC and (c-d) HMVEC. Fluorescence microplate reader based measurements were also performed to measure specific
fluorescence intensity of 2-OH-E+ in (e) HUVEC and HMVEC treated with high glucose. For both types of DHE measurements, cells grown in
5.6 mM D-glucose were used as control. **p ≤ 0.01 significantly higher than control for respective cells type.

Thus, even without any change in gene expression levels,
as seen in our results, NAD(P)H oxidase family enzymes
can regulate O2‾ production in HUVEC. Additionally,
eNOS uncoupling and mitochondrial ROS can contribute
to increased cellular O2‾, as seen in results [14,45].
In our study, hyperpolarized mitochondrial membrane
suggested the involvement of mitochondria in O2‾ production in HUVEC. However, a depolarized mitochondrial
membrane in hyperglycemic-HMVEC indicated involvement of non-mitochondrial O2‾ production sources.
Though the specific details of O2‾ production sources in
HMVEC are not available in the literature, our results
suggested an increased involvement of NAD(P)H oxidase

family enzyme (CYBA (non-significant), NOX1, and
NOX4) in hyperglycemic HMVEC.
Along with increased involvement of O2‾ production
sources, we also showed downregulated SOD1 (non-significant) and SOD2 expression in HUVEC. Downregulated
gene expressions of SODs were suggestive to reduced O2‾
clearance in high glucose treated HUVEC. In HMVEC,
gene expression of SOD1 and SOD2 (non-significant) simultaneously increased with O2‾ levels, and CYBA (nonsignificant), NOX1, and NOX4 expression during hyperglycemia. Thus, hyperglycemia can induce regulation in
gene expression of pro- and anti-oxidant sources resulting
in increased O2‾ levels through a complex interplay
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Figure 7 H2O2 production profile in high glucose treated HUVEC and HMVEC. Levels of H2O2 were measured in media supernatant of
(a) HUVEC and (b) HMVEC treated with either 5.6 mM (control) or 25 mM D-glucose. Cells grown in media with 5.6 mM D-glucose were used
as control. **p ≤ 0.006 significantly higher than control for respective cells type.

amongst them. Previous studies from our group have analyzed the complex interactions amongst oxidative stress
and SOD [46,47]. Moreover, enzymatic activity regulation
in pro- and anti-oxidant sources could also influenced
increased O2‾ levels as seen in high glucose treated
HMVEC [36,37].
Interplay among mitochondrial membrane polarization
and peroxidase clearance enzyme yielded to differential
H2O2 in both endothelial cells

Excess production of H2O2 through rapid O2‾ dismutation also contributes to hyperglycemia-dependent oxidative
stress. H2O2 is one of the stable forms of free radicals during oxidative stress. However, H2O2 levels in hyperglycemic
condition are variably reported in literature and hence
its role in vasoregulatory activity remains unclear [38].

Consistent with the literature [48,49], we showed increased
levels of H2O2 in HUVEC. However, no-change was observed in H2O2 levels of HMVEC during high glucose
exposure. Furthermore, we observed higher basal level
H2O2 in HUVEC compared to HMVEC in controls. Under
physiological condition, H2O2 promotes NO production
and maintains cell growth [50,51]. Basal H2O2 levels are
not well characterized across vasculature but our results
suggests a possibility of higher basal production of H2O2 in
macrovessel (HUVEC) compared to microvessel (HMVEC).
The H2O2 levels are dependent on O2‾ dismutation reaction, peroxide clearance, NAD(P)H oxidase activation
and crosstalk with mitochondria, and mitochondrial
hyperpolarization.
In HUVEC, downregulated SOD2 and CAT gene expression, similar as observed by Felice et al. [52], and
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Figure 8 Mitochondrial membrane polarization in HUVEC and HMVEC following high glucose treatment for 24 hours. Using JC-10
mitochondrial membrane polarization was measured in both HUVEC and HMVEC after 24 hours of high glucose treatment. Mitochondrial
membrane polarization of high glucose treated HUVEC was evaluated through measurement of JC-10 aggregates (Red) and monomers (Green)
using fluorescence microscopy and microplate reader. a) Overlapped fluorescence images of red and green fluorescence intensities along with
Hoescht-33342 based nuclear stain were used to show hyperpolarized mitochondrial membrane in high glucose treated HUVEC. b) Similarly, ratio
of red and green fluorescence intensities were plotted to illustrate mitochondrial membrane hyperpolarization in high glucose treated HUVEC.
**p ≤ 0.05 significantly higher than 5.6 mM D-glucose exposure treatment in HUVEC. c) Overlapped fluorescence images of red and green
fluorescence intensities along with Hoescht-33342 based nuclear stain were used to show depolarized mitochondrial membrane in high glucose
treated HMVEC. d) Ratio of red and green fluorescence intensities were plotted to show high glucose exposure-induced mitochondrial
membrane depolarization in HMVEC. **p ≤ 0.05 significantly higher than 25 mM D-glucose exposure concentration in HMVEC.

their reduced activity under high glucose exposure, as
shown by Zhang et al. [42], suggested decreased O2‾ and
H2O2 removal in HUVEC. As a result increased H2O2
level prevailed along with higher O2‾ level in HUVEC following high glucose exposure. Moreover, hyperpolarized
mitochondrial membrane, associated with increased H2O2
production, in HUVEC contributed to overall H2O2 levels
in hyperglycemia [53]. Additionally, we observed downregulated (non-significant) gene expression levels of GPX1,
TXNRD1, TXNRD2, PRDX1 and NFE2L2 in HUVEC,
which plays a pivotal role in peroxidase clearance and
promoting an anti-oxidative environment. Hyperglycemiainduced unaltered GPX1 was similar as reported by
Felice et al. [52]. Not much detail is available in literature
for hyperglycemia-induced gene expression of NFE2L2,
TXNRD1, TXNRD2 and PRDX1 in HUVEC. In our results for HUVEC, hyperglycemia-induced regulation of
these peroxidase clearance genes to pro-oxidative cellular
environment and a reduced peroxide clearance.
Interestingly in contrast to HUVEC, the gene expression of ROS clearance enzymes, SOD1, GPX1, TXNRD1,
TXNRD2, and PRDX1 were upregulated in HMVEC
under hyperglycemia. ROS clearance transcription factor,
NFE2L2 was also upregulated (though non-significant,
p = 0.06) under similar conditions. Upregulated SOD1
expression level suggests an increased O2‾ processing to
H2O2 in high glucose treated HMVEC. But simultaneous
upregulation of GPX1, TXNRD1, TXNRD2, PRDX1 and
NFE2L2 expression indicated a balanced increase in
H2O2 clearance in high glucose treated HMVEC. Along
with simultaneous expression of SOD1 and peroxide
clearance enzymes, we observed no increase in H2O2
level indicating a predominant involvement of peroxide
clearance enzymes in HMVEC under high glucose exposure. Additionally our results also showed depolarized
mitochondrial membrane along with increased UCP1
gene expression, which has been shown to downplay
mitochondrial H2O2 production in HMVEC [53]. Since
there was not enough evidence in literature, we used our
results from experiments using HUVEC as a reference
to report these differential findings from HMVEC for
the first time.

Differential regulation of mitochondrial membrane
polarization through UCP1 expression

Uncoupling proteins (UCPs) are functionally linked to
shunt electron transport chain and reduce mitochondrial
membrane polarization in endothelial cells. Several studies explored this trait of UCPs by overexpressing UCP1,
UCP2, and UCP3 to ameliorate mitochondrial hyperpolarization and hence to reduce ROS production in endothelial cells [45,54]. However, it was believed that UCP1
expression was exclusive to brown adipose tissue, but increasing number of recent studies have reported presence of UCP1 transcription in other tissues and
specifically in endothelial cells from bovine and human
retina [55]. In our results, we reported the presence of
UCP1 transcription in both HUVEC and HMVEC. We
also reported that hyperglycemia did not change UCP1
gene expression in HUVEC but upregulated it in
HMVEC (though non-significant, p = 0.06). As observed
by Nishikawa et al. [45,54], increased UCP1 gene expression observed in HMVEC can be linked to depolarized
mitochondrial membrane and unchanged H2O2 production [53]. As the current state of literature is not clear
on regulation and role of all UCPs in endothelial cells, it
will be important to characterize gene expression of
other UCPs in future studies.
Hyperglycemia-induced differential epigenetic regulation
in ECs from different vasculature

Emerged concepts in vascular metabolic memory have
explained limited efficacies of antihyperglycemic treatment
and its late effect in type 2 diabetes [56]. The theories justifying such involvement of vascular metabolic memory have
implicated non-reversible epigenetic regulation [57]. As
observed in our results, 24 hours of hyperglycemiainduced differentially regulated gene expression in HUVEC
and HMVEC. In specific, high occurrences of gene expression changes in HMVEC in our study provided the evidence for the hypothesis in vascular metabolic memory
that suggests microvasculature precedes macrovasculature
in epigenetic regulation forming vascular metabolic memory [58]. Such differential regulation, even from short
exposure, may explain non-uniform epigenetic regulation
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across vasculature. Further research will be of importance
to understand the involvement of vasculature specific
pathologies and the role of vascular metabolic memory in
endothelial dysfunction.

Conclusion
In conclusion, we studied the pro and anti-oxidant sources
contributions under hyperglycemic endothelial cell oxidative stress. Hyperglycemia induced a pro-oxidative environment in both HUVEC and HMVEC through increased
O2‾ production. We demonstrated that ECs have differential involvement of oxidative stress regulating mechanisms
from NOS enzymes, NAD(P)H oxidase enzymes, ROS
clearance enzymes and antioxidant gene expression in hyperglycemia that results in significantly different outcome
of mitochondrial membrane polarization and H2O2 level.
Such interplay among key enzyme gene expression, mitochondrial membrane polarization and O2‾ and H2O2 level
regulation indicated the complexity of processes that regulates vasculature specific endothelial behavior in hyperglycemia. High occurrences of gene expression changes in
HMVEC in this study supports the hypothesis that microvasculature precedes macrovasculature in epigenetic regulation forming vascular metabolic memory. Identifying
genomic phenotype and corresponding functional changes
in hyperglycemic endothelial dysfunction will provide a
suitable systems biology approach for understanding
underlying mechanisms and possible effective therapeutic
intervention.
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